Related Experiment Video
Updated: Apr 23, 2026
08:40
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
Published on: August 1, 2013
17.7K
Optimizing dendritic cell preparation for fusion with melanoma cells
Yang Li1, Lu Zhang, Shouyu Wang
1Department of Orthopaedics, First Affiliated Hospital, Dalian Medical University, Dalian 116000, Liaoning Province, China,email: yangliyyyl@163.com.
Iranian Journal of Immunology : IJI
|October 1, 2014
Summary
Optimizing dendritic cell (DC) preparation and fusion with melanoma cells is key for cancer immunotherapy. This study found that 1000 U/ml GM-CSF and 500 U/ml IL-4 maximize mature DC quantity, while PEG-3000 enhances fusion efficiency.
Area of Science:
- Immunotherapy
- Cell Biology
- Cancer Research
Background:
- Dendritic cell (DC) fusion with melanoma cells can enhance anti-tumor immunity.
- Current limitations include insufficient DC quantities and low fusion efficiency.
Purpose of the Study:
- To determine optimal conditions for DC preparation and cell fusion.
- To define dosages of stimulating factors and induction conditions.
Main Methods:
- Murine bone marrow-derived DCs were cultured with varying concentrations of GM-CSF and IL-4.
- DC maturation was assessed via flow cytometry (MHC-II, CD11c, CD80, CD83).
- DC-melanoma fusion cells were generated using polyethylene glycol (PEG) of different molecular weights; efficiency was measured by FACS.
Main Results:
- Optimal DC quantity (1.69 ± 0.04 ×10⁶ ml⁻¹) achieved with 1000 U/ml GM-CSF and 500 U/ml IL-4.
- MHC-II and CD83 expression decreased significantly by day 7 compared to day 3.
- PEG-3000 yielded significantly higher fusion efficiency (15.4 ± 0.56%) than PEG-4000 (11.1 ± 0.45%).
Conclusions:
- Optimal mature DC yield requires 1000 U/ml GM-CSF and 500 U/ml IL-4.
- PEG-3000 is the most effective agent for inducing high DC-melanoma fusion efficiency.
